Oral Lichen Planus and Systemical Oncological Comorbidities
Key facts
- Who runs it
- Catholic University of the Sacred Heart
- Where
- Italy1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 1,517 people enrolled
- Started
- 2 Jan 2023
- Ended
- 2 Dec 2023
- Type of study
- Observational, 2 groups
- Treatments tested
- Checking of appropriateness of OLP diagnosis
- Record updated
- 7 June 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Patients of both sexes, consecutively enrolled in a 1:2 ratio
- Age over 18 yo
- Previous clinical and histological diagnosis of OLP
- Patients of both sexes, consecutively enrolled in a 1:2 ratio
- Age over 18 yo
Who cannot take part
- Previous clinical and histological diagnosis of OLP
- Age under 18 yo
- Age under 18 yo
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Lichen planus (LP) is a chronic mucocutaneous inflammatory disease of unknown etiology.
Read full original descriptionShow less
In its oral variant, oral lichen planus (OLP) has a reported prevalence ranging from 0.5% to 2.2% in the general population. The disease typically occurs between the ages of 30 and 60. Although the pathogenetic mechanism and the triggering factor remain unknown, an immune-mediated pathogenesis and the role of factors such as stress, anxiety, diabetes, other autoimmune diseases, hypertension, intestinal pathologies, chronic liver diseases, hypercholesterolemia, infections have been hypothesized , contact with dental materials, tumors and genetic predisposition to cancer.
Oral lichen planus is one of the potentially malignant disorders, showing a malignant transformation rate of 1.4%.
A preliminary analysis conducted in our research center has shown a correlation between OLP and systemic tumors, both solid and haematological, involving areas not involved in lesions attributable to OLP.
According to these data, the objective of the study is to evaluate whether there is an association between OLP and peripheral tumors, both solid and haematological.
The primary objective will be to investigate the possible existence of a statistically significant association between OLP and the development of systemic oncological pathologies.
Secondary objective will be to investigate the existence of an association between the various forms of OLP and specific oncological pathologies and to evaluate whether the presence of other systemic pathologies and lifestyle factors (diabetes, hypertension, chronic liver disease, smoking, alcohol, infection by HPV, HCV, etc ...) could influence such association (primary outcome).
The objectives will be pursued through the analysis of data collected from the medical records of patients belonging to the General Dentistry and Orthodontic Outpatient Clinics at the "Agostino Gemelli" Teaching Hospital and in the Oral Pathology Outpatient Clinics of the other centers involved.
The 2 groups in the trial
- Case Group
1. Patients of both sexes, consecutively enrolled in a 1:2 ratio 2. Age over 18 yo 3. Previous clinical and histological diagnosis of OLP
Treatment: Checking of appropriateness of OLP diagnosis
- Control Group
1. Patients of both sexes, consecutively enrolled in a 1:2 ratio 2. Age over 18 yo
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Oral Lichen Planus and Systemical Oncological Comorbidities: Case-control Multicenter Observational Clinical Study
- Publications
- Record updated
- 7 June 2024